Browsing by Author rp00466

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 265 to 284 of 364 < previous   next >
TitleAuthor(s)Issue DateViews
 
Recent Insights Into the Role of Immune Cells in Alcoholic Liver Disease
Journal:Frontiers in Immunology
Li, STan, HYWang, NFeng, YWang, XFeng, Y
2019
14
 
Recent Progress on Anti-Liver Fibrosis Candidates in Patents of Herbal Medicinal Products
Journal:Recent Patents on Food, Nutrition & Agriculture
Wang, XBFeng, YWang, MNCheung, FWong, CW
2012
55
 
Recent progress on anticancer candidates in patents of herbal medicinal products
Journal:Recent Patents on Food, Nutrition and Agriculture
Feng, YWang, NZhu, MFeng, YLi, HTsao, S
2011
109
 
Red pigment from Saw Palmetto: a natural product for potential alternative cancer treatment
Proceeding/Conference:EACR-AACR-SIC Special Conference 2015
Feng, YOkuda, STan, HYWang, NTsao, SWTakahashi, M
2015
67
 
Relationship exploration of diabetic combined with cholangiocarcinoma and one case report
Journal:香港中醫雜誌
Lam, PYFeng, Y
2013
 
Relationship Exploration Of Diabetic Combined With Colorectal Cancer And One Case Treated By Granular Powder Of Chinese Medicines.
Journal:Hong Kong Chinese Medical Magazine
Lam, PYFeng, Y
2014
34
 
Renal herb formula protects against hyperuricemic nephropathy by inhibiting apoptosis and inflammation
Journal:Phytomedicine
Tang, GYLi, SXu, YZhang, CXu, XYXu, LWang, NFeng, YB
9-May-2023
 
Repression of WT1-Mediated LEF1 Transcription by Mangiferin Governs β-Catenin-Independent Wnt Signalling Inactivation in Hepatocellular Carcinoma
Journal:Cellular Physiology and Biochemistry
Tan, HYHWang, NLI, SHONG, MGUO, WMan, KCheng, CChen, ZFeng, Y
2018
50
 
Research Progress on the Molecular Mechanisms underlying the therapeutic benefits of Chinese Medicines in hepatocellular carcinoma
Proceeding/Conference:The 18th Meeting of Consortium for Globalization of Chinese Medicine (CGCM)
GUO, WTan, HYHWang, NFeng, Y
2019
44
 
Research Progress on the Therapeutic Effect of Polysaccharides on Non-Alcoholic Fatty Liver Disease through the Regulation of the Gut-Liver Axis
Journal:International Journal of Molecular Sciences
Chen, XLiu, MHTang, JWang, NFeng, YBMa, HT
1-Oct-2022
 
Resource, chemical structure and activity of natural polysaccharides against alcoholic liver damages
Journal:Carbohydrate Polymers
Yang, YJi, JDi, LLi, JHu, LQiao, HWang, LFeng, Y
2020
37
 
Review and Prospect of Chinese Medicine education in Hong Kong
Journal:Education of Chinese Medicine
Feng, YLI, LLao, L
2014
 
Role of big data and network pharmacology in drug discovery of Chinese Medicines
Proceeding/Conference:International Symposium on Good Pharmacology Practice for Chinese Medicines and the 2nd International Symposium on Wudang Local Chinese Medicines
Feng, Y
2019
6
 
SBP2 deficiency in adipose tissue macrophages drives insulin resistance in obesity
Journal:Science Advances
Wang, NTan, HYHLi, SWang, DIXu, YZhang, CXia, WChe, CMFeng, Y
2019
 
Scutellaria baicalensis and Cancer Treatment: Recent Progress and Perspectives in Biomedical and Clinical Studies
Journal:The American Journal of Chinese Medicine
Cheng, CChen, JTan, HYHWang, NChen, ZFeng, Y
2018
 
Selenium in the prevention and treatment of hepatocellular carcinoma: from biomedical investigation to clinical application
Book:Importance of Selenium in the Environment and Human Health
Cheng, CWang, NFeng, Y
2020
45
 
Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy – Interim analysis of an add-on, randomised, controlled, multi-centre, open-label pragmatic trial
Proceeding/Conference:International Congress of Chinese nephrologists
Chan, KWKwong, ASKLui, SLIp, TPChan, GCWCowling, BJYiu, WHWong, WLDLI, BLI, YFeng, YTan, KCBChan, YYLeung, JCKLai, KNTang, SCW
2017
106
 
Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy – Preliminary results of an add-on, randomised, controlled, multi-centre, open-label pragmatic trial
Proceeding/Conference:Journal of the American Society of Nephrology
Chan, KWKwong, ASKLui, SLIp, TPChan, GCWCowling, BJYiu, WHWong, WLDLi, BLi, YFeng, YTan, KCBChan, YYLeung, JCKLai, KNTang, SCW
2017
 
Semi-individualised Chinese medicine treatment as an adjuvant management for diabetic nephropathy: a pilot add-on, randomised, controlled, multicentre, open-label pragmatic clinical trial
Journal:BMJ Open
Chan, KWIp, TPKwong, ASKLui, SLChan, GCWCowling, BJYiu, WHWong, DWLLiu, YFeng, YTan, KCBChan, LYYLeung, JCKLai, KNTang, SCW
2016
89
 
Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy: Interim analysis of an add-on, randomised, controlled, multi-centre, open-label pragmatic trial
Proceeding/Conference:Hong Kong Medical Journal
Chan, KWKwong, ASKLui, SLIp, TPChan, GCWCowling, BJYiu, WHWong, WLDLi, BLi, YFeng, YTan, KCBChan, YYLeung, JCKLai, KNTang, SCW
2018
94
Showing results 265 to 284 of 364 < previous   next >